These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7804463)

  • 1. Developing new treatments for muscle disease: prospects and promise.
    Griggs RC
    Curr Opin Neurol; 1994 Oct; 7(5):422-6. PubMed ID: 7804463
    [No Abstract]   [Full Text] [Related]  

  • 2. New treatments for neuromuscular disease: optimism and obstacles.
    Lochmüller H; Griggs RC
    Neurotherapeutics; 2008 Oct; 5(4):497-8. PubMed ID: 19019299
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuromuscular diseases: hope and hurdles in clinical trials.
    Verschuuren JJ
    Lancet Neurol; 2017 Jan; 16(1):12-13. PubMed ID: 27979339
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel molecular mechanisms of neuromuscular disease: implications for therapy. Abstracts of the Muscle Study Group Meeting. September 16-18, 2013. Oxford, United Kingdom.
    Muscle Nerve; 2013 Sep; 48 Suppl 1():S1-13. PubMed ID: 24038082
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives on best practices for gene therapy programs.
    Cheever TR; Berkley D; Braun S; Brown RH; Byrne BJ; Chamberlain JS; Cwik V; Duan D; Federoff HJ; High KA; Kaspar BK; Klinger KW; Larkindale J; Lincecum J; Mavilio F; McDonald CL; McLaughlin J; Weiss McLeod B; Mendell JR; Nuckolls G; Stedman HH; Tagle DA; Vandenberghe LH; Wang H; Wernett PJ; Wilson JM; Porter JD; Gubitz AK
    Hum Gene Ther; 2015 Mar; 26(3):127-33. PubMed ID: 25654329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular disease: muscle.
    Fardeau M
    Curr Opin Neurol; 2013 Oct; 26(5):516-8. PubMed ID: 23995280
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuromuscular diseases: progress in gene discovery drives diagnostics and therapeutics.
    Fratta P; Hanna MG
    Lancet Neurol; 2015 Jan; 14(1):13-4. PubMed ID: 25496885
    [No Abstract]   [Full Text] [Related]  

  • 8. Adding more muscle and nerve to clinical trials.
    Conwit RA; Bhanushali MJ; Porter JD; Kaufmann P; Gutmann L
    Muscle Nerve; 2011 Nov; 44(5):695-702. PubMed ID: 22006684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular diseases: milestones in development of treatments.
    Bushby K
    Lancet Neurol; 2011 Jan; 10(1):11-3. PubMed ID: 21163438
    [No Abstract]   [Full Text] [Related]  

  • 10. New therapies for neuromuscular diseases in 2018.
    Shah AM; Al-Chalabi A
    Lancet Neurol; 2019 Jan; 18(1):12-13. PubMed ID: 30563673
    [No Abstract]   [Full Text] [Related]  

  • 11. Bibliography. Current world literature. Neuromuscular disease: muscle.
    Curr Opin Neurol; 2000 Oct; 13(5):593-601. PubMed ID: 11073369
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromuscular disease: new insights and avenues for therapy.
    Scotter EL; Shaw CE
    Lancet Neurol; 2013 Jan; 12(1):13-5. PubMed ID: 23237893
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hereditary neuromuscular diseases].
    Abramova MF
    Med Sestra; 1989 Oct; 48(10):19-23. PubMed ID: 2615614
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular diseases: new hopes for alleviation and elimination.
    Ludolph AC
    Lancet Neurol; 2009 Jan; 8(1):16-7. PubMed ID: 19081506
    [No Abstract]   [Full Text] [Related]  

  • 15. Current concerns in the therapy of neuromuscular disorders.
    Dubowitz V
    Neuromuscul Disord; 2011 Jan; 21(1):3. PubMed ID: 21130653
    [No Abstract]   [Full Text] [Related]  

  • 16. Antisense oligonucleotides for therapeutic interventions in neuromuscular diseases.
    Danos O
    Hum Gene Ther; 2013 May; 24(5):470-1. PubMed ID: 23675648
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuromuscular Disorders in Children and Adolescents.
    Korinthenberg R
    Neuropediatrics; 2017 Aug; 48(4):209-210. PubMed ID: 28738441
    [No Abstract]   [Full Text] [Related]  

  • 18. Paediatric neurology: from molecular mechanisms to targeted treatments.
    Muntoni F; Cross JH
    Lancet Neurol; 2015 Jan; 14(1):16-8. PubMed ID: 25496887
    [No Abstract]   [Full Text] [Related]  

  • 19. Inherited neuromuscular diseases. Translation from pathomechanisms to therapies.
    Espinós C; Felipo V; Palau F
    Adv Exp Med Biol; 2009; 652():v-vi. PubMed ID: 20235380
    [No Abstract]   [Full Text] [Related]  

  • 20. Current perspectives in the treatment of mitochondrial DNA diseases.
    Turnbull DM; Lightowlers RN; Taylor RW
    Funct Neurol; 2001; 16(4 Suppl):89-96. PubMed ID: 11996536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.